Kingworld Medicines Group Limited (HKG:1110)

Market Cap	248.83M -21.8%
Revenue (ttm)	1.02B -13.5%
Net Income	12.55M -72.9%
EPS	0.02 -73.3%
Shares Out	592.46M
PE Ratio	19.61
Forward PE	n/a
Dividend	0.03 (7.55%)
Ex-Dividend Date	Jun 5, 2025

Volume	1,328,000
Open	0.4100
Previous Close	0.4250
Day's Range	0.4100 - 0.4350
52-Week Range	0.4050 - 0.7800
Beta	0.85
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 3, 2026

About Kingworld Medicines Group

Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution, manufacture, and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, and Kingworld Imada Red Flower Oil brands. It also manufactur...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 732
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1110

Financial Performance

In 2025, Kingworld Medicines Group's revenue was 917.34 million, a decrease of -13.55% compared to the previous year's 1.06 billion. Earnings were 11.28 million, a decrease of -72.85%.

Financial numbers in CNY